Why the study?
Reports suggest ethnic differences in therapeutic requirements and responses to oral antithrombotic therapy, with East Asians showing lower ischemic and higher bleeding outcomes compared to Westerners.
Does oral antithrombotic therapy have different therapeutic requirements and responses in East Asians compared to Westerners with cardiovascular disease?
Does oral antithrombotic therapy have different therapeutic requirements and responses in East Asians compared to Westerners with cardiovascular disease?
This review highlights the need for a more effective and targeted antithrombotic treatment strategy in East Asians due to their unique risk profile of lower ischemic and higher bleeding outcomes compared to Westerners.
No takes yet. Share an insight, caveat, or question.
May inform ethnicity-specific antithrombotic strategies in East Asians; leaves open confirmation via dedicated RCTs.
Cho et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: